Global ADME Toxicology Testing Market to Reach $14.05
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Opal Computational Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The
Former Ernst and Young Senior Partner to serve as Chair of Audit Committee BOSTON, Jan. 4, 2024 /PRNewswire/ -- Valo Health, Inc , a technology company focused on utilizing large scale data and...
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The
Novo Nordisk and Valo Health have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases.
Novo Nordisk A/S and Valo Health, Inc. announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation powered by artificial intelligence (AI). The collaboration between the two organizations will leverage the capabilities of Valo’s Opal Computational Platform™ including access to real-world patient data, AI-enabled small molecule discovery and Biowire® human tissue modelling platform designed to speed up the discovery and development process.